|
1
|
Dean EJ, Ward T, Pinilla C, Houghton R,
Welsh K, Makin G, Ranson M and Dive C: A small molecule inhibitor
of XIAP induces apoptosis and synergises vinorelbine and cisplatin
in NSCLC. Br J Cancer. 102:97–103. 2010. View Article : Google Scholar :
|
|
2
|
Janet WT and Elizabeth HB: Drug resistance
mechanism in non-small cell lung carcinoma. J Can Res Updates.
2:265–282. 2013.
|
|
3
|
Chen X, Yang L, Zhang N, Turpin JA,
Buckheit RW, Osterling C, Oppenheim JJ and Howard OM: Shikonin, a
component of Chinese herbal medicine, inhibits chemokine receptor
function and suppresses human immunodeficiency virus type 1.
Antimicrob Agents Chemother. 47:2810–2816. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeh CC, Kuo HM, Li TM, Lin JP, Yu FS, Lu
HF, Chung JG and Yang JS: Shikonin-induced apoptosis involves
caspase-3 activity in a human bladder cancer cell line (T24). In
Vivo. 21:1011–1019. 2007.
|
|
5
|
Wiench B, Eichhorn T, Paulsen M and
Efferth T: Shikonin directly targets mitochondria and causes
mitochondrial dysfunction in cancer cells. Evid Based Complement
Alternat Med. 2012:7260252012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee MJ, Kao SH, Huang JE, Sheu GT, Yeh CW,
Hseu YC, Wang CJ and Hsu LS: Shikonin time-dependently induced
necrosis or apoptosis in gastric cancer cells via generation of
reactive oxygen species. Chem Biol Interact. 211:44–53. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu C, Yin L and Chen J and Chen J: The
apoptotic effect of shikonin in human papillary thyroid carcinoma
cells through mitochondrial pathway. Tumour Biol. 35:1791–1798.
2014. View Article : Google Scholar
|
|
8
|
Murakami D, Tsujitani S, Osaki T, Saito H,
Katano K, Tatebe S and Ikeguchi M: Expression of phosphorylated Akt
(pAkt) in gastric carcinoma predicts prognosis and efficacy of
chemotherapy. Gastric Cancer. 10:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roy HK, Olusola BF, Clemens DL, Karolski
WJ, Ratashak A, Lynch HT and Smyrk TC: AKT proto-oncogene
overexpression is an early event during sporadic colon
carcinogenesis. Carcinogenesis. 23:210–205. 2002. View Article : Google Scholar
|
|
10
|
Zinda MJ, Johoson MA, Paul JD, Horn C,
Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT and
Graff JR: Akt-1, -2 and -3 are expressed in both normal and tumor
tissues of the lung, breast, prostate, and colon. Clin Cancer Res.
7:2475–2479. 2001.PubMed/NCBI
|
|
11
|
Pennock S and Wang Z: A tale of two Cbls:
Interplay of c-Cbl and Cbl-b in epidermal growth factor receptor
downregulation. Mol Cell Biol. 28:3020–3037. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qu J, Zhao M, Teng Y, Zhang Y, Hou K,
Jiang Y, Yang X, Shang H, Qu X and Liu Y: Interferon-α sensitizes
human gastric cancer cells to TRAIL-induced apoptosis via
activation of the c-CBL-dependent MAPK/ERK pathway. Cancer Biol
Ther. 12:494–502. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Xu L, Qu X, Zhao M, Yu P, Kang J,
Liu Y and Hu X: Cbl-regulated Akt and ERK signals are involved in
β-elemene-induced cell apoptosis in lung cancer cells. Mol Med Rep.
4:1243–1246. 2011.PubMed/NCBI
|
|
14
|
Li Y, Qu X, Qu J, Zhang Y, Liu J, Teng Y,
Hu X, Hou K and Liu Y: Arsenic trioxide induces apoptosis and G2/M
phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and
thereby regulate p53 activation. Cancer Lett. 284:208–215. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nie YK, Zhu LS and Yu HM: Shikonin
inhibits the proliferation and induces the apoptosis of human HepG2
cells. Can J Physiol Pharmacol. 88:1138–1146. 2010. View Article : Google Scholar
|
|
16
|
Chang IC, Huang YJ, Chiang TI, Yeh CW and
Hsu LS: Shikonin induces apoptosis through reactive oxygen
species/extracellular signal-regulated kinase pathway in
osteosarcoma cells. Biol Pharm Bull. 33:816–824. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang H, Zhou P, Huang H, Chen D, Ma N, Cui
QC, Shen S, Dong W, Zhang X, Lian W, Wang X, Dou QP and Liu J:
Shikonin exerts antitumor activity via proteasome inhibition and
cell death induction in vitro and in vivo. Int J Cancer.
124:2450–2459. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng HM, Qiu YK, Wu Z and Zhao YF: DNA
damage induced by shikonin in the presence of Cu(II) ions:
potential mechanism of its activity to apoptotic cell death. J
Asian Nat Prod Res. 13:12–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng YW, Chang CY, Lin KL, Hu CM, Lin CH
and Kang JJ: Shikonin derivatives inhibited LPS-induced NOS in RAW
264.7 cells via downregulation of MAPK/NF-kappaB signaling. J
Ethnopharmacol. 120:264–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu Z, Wu LJ, Tashiro S, Onodera S and
Ikejima T: Phosphorylated extracellular signal-regulated kinase
up-regulated p53 expression in shikonin-induced HeLa cell
apoptosis. Chin Med J (Engl). 118:671–677. 2005.
|
|
21
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: a play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li T, Yan F, Wang R, Zhou H and Liu L:
Shikonin suppresses human T lymphocyte activation through
inhibition of IKK β activity and JNK phosphorylation. Evid Based
Complement Alternat Med. 2013:3795362013. View Article : Google Scholar
|
|
23
|
Tsao AS, McDonnell T, Lam S, Putnam JB,
Bekele N, Hong WK and Kurie JM: Increased phospho-AKT (Ser (473))
expression in bronchial dysplasia: implications for lung cancer
prevention studies. Cancer Epidemiol Biomarkers Prev. 12:664–666.
2003.
|
|
24
|
Brognard J, Clark AS, Ni Y and Dennis PA:
Akt/protein kinase B is constitutively active in non-small cell
lung cancer cells and promotes cellular survival and resistance to
chemotherapy and radiation. Cancer Res. 61:3986–3997.
2001.PubMed/NCBI
|
|
25
|
Swaminathan G and Tsygankov AY: The Cbl
family proteins: ringleaders in regulation of cell signaling. J
Cell Physiol. 209:21–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naramura M, Band V and Band H:
Indispensable roles of mammalian Cbl family proteins as negative
regulators oprotein tyrosine kinase signaling: Insights from in
vivo models. Commun Integr Biol. 4:159–162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thien CB, Dagger SA, Steer JH, Koentgen F,
Jansen ES, Scott CL and Langdon WY: c-Cbl promotes T cell
receptor-induced thymocyte apoptosis by activating the
phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem.
285:10969–10981. 2010. View Article : Google Scholar : PubMed/NCBI
|
